Emmaus Life Sciences (OTCMKTS:EMMA – Get Rating) and Nature’s Sunshine Products (NASDAQ:NATR – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings. Institutional & Insider Ownership 75.2% of Nature’s […]
/PRNewswire/ Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,.